SHARE CAPITAL | 14. SHARE CAPITAL 14.1 Authorized 14.2 Issued and Outstanding Common Shares: The details for the common share issuances during the year ended December 31, 2023 are as follows: a. During the year ended December 31, 2023, the Company issued 925,667 0.87 1.01 48 819 The details for the common share issuances during the year ended December 31, 2022 were as follows: b. During the year ended December 31, 2022, 4,444,445 2.70 12,000 1,283 During the year ended December 31, 2022, the Company also issued 5,118,554 0.79 3.65 205 6,244 c. During the year ended December 31, 2022, 166,000 d. During the year ended December 31, 2022, 66,661 1.13 75 The details for the common share issuances during the year ended December 31, 2021 were as follows: e. During the year ended December 31, 2021, 4,114,242 4.27 17,563 3,567 f. During the year ended December 31, 2021, 1,924,721 3.18 6,128 g. During the year ended December 31, 2021, 256,662 1.62 416 14.3 Share Purchase Warrants A summary of the Company’s share purchase warrants are as follows: Schedule of share purchase warrants Number of Weighted Average Exercise Price C$ Outstanding, December 31, 2020 1,934,100 3.89 Issued 2,407,304 6.64 Forfeited (9,379 ) 4.50 Exercised (1,924,721 ) 3.89 Outstanding, December 31, 2021 2,407,304 6.64 Issued 5,577,778 3.84 Cancelled (412,000 ) 4.50 Outstanding, December 31, 2022 7,573,082 4.53 Issued 2,250,000 1.45 Cancelled (1,000,000 ) 2.25 Outstanding, December 31, 2023 8,823,082 4.00 During the year ended December 31, 2023, the Company issued 1,500,000 The warrants expire on October 4, 2024. 1,000,000 warrants from the previous extension on June 15, 2022, were cancelled. During the year ended December 31, 2023, the Company issued 750,000 During the year ended December 31, 2022, the Company issued 4,444,445 133,333 During the year ended December 31, 2022, the Company issued 1,000,000 During the year ended December 31, 2021, the Company issued 1,995,304 During the year ended December 31, 2021, the Company issued 412,000 14.4 Directors, Consultants, and Employee stock options The Company has adopted a share option plan for which options to acquire up to 10% of the issued share capital, at the award date, may be granted to eligible optionees from time to time. Generally, share options granted have a maximum term of five years, and a vesting period and exercise price determined by the directors. A summary of the Company’s directors, consultants, and employee stock options are as follows: Schedule of share option activity Number of Weighted Average Exercise Price C$ Outstanding, December 31, 2020 1,173,320 2.70 Issued 684,999 6.71 Exercised (256,662 ) 2.06 Outstanding, December 31, 2021 1,601,657 4.52 Issued 387,500 1.60 Forfeited (341,670 ) 5.21 Exercised (66,661 ) 1.40 Outstanding, December 31, 2022 1,580,826 3.79 Issued 602,000 1.17 Forfeited (514,999 ) 3.02 Outstanding, December 31, 2023 1,667,827 3.08 During the year ended December 31, 2023, the Company granted 602,000 During the year ended December 31, 2022, the Company granted 387,500 During the year ended December 31, 2021, the Company granted 524,999 During the year ended December 31, 2021, the Company granted 160,000 During the year ended December 31, 2023, the Company recognized $ 88 116 814 Schedule of weighted average assumptions December 31, 2023 December 31, 2022 December 31, 2021 Fair value at grant date (C$) $ 0.55 $ 0.75 $ 4.20 Fair value at grant date (US$) $ 0.42 $ 0.56 $ 3.27 Risk-free interest rate 4.01 % 3.47 % 0.42 % Expected life of options 5 5 4 Expected dividend rate 0 % 0 % 0 % Annualized volatility 80 % 97 % 90 % Forfeiture rate 15 % 14 % 3 % The following tables summarize information about the Company’s stock options outstanding at December 31, 2023: Schedule of stock options outstanding Options Outstanding Options Exercisable Exercise Remaining Contractual Life (Years) Expiry Date C$ January 17, 2019 166,666 166,666 2.40 0.05 January 17, 2024 November 15, 2019 233,333 233,333 1.50 0.88 November 15, 2024 November 28, 2019 16,666 16,666 1.56 0.91 November 28, 2024 May 4, 2020 24,999 24,999 1.20 1.34 May 4, 2025 November 23, 2020 66,664 66,664 6.15 1.90 November 23, 2025 January 12, 2021 333,333 333,333 6.51 2.03 January 11, 2026 February 1, 2021 41,666 41,666 9.36 2.09 January 31, 2026 April 27, 2021 60,000 50,000 7.24 2.32 April 26, 2026 March 31, 2022 40,000 20,000 2.98 3.25 March 30, 2027 November 25, 2022 82,500 27,500 1.30 3.90 November 24, 2027 May 11, 2023 50,000 8,333 1.02 4.36 May 10, 2028 November 15, 2023 552,000 — 1.30 4.88 November 14, 2028 Total 1,667,827 989,160 14.5 Restricted Share Units Pursuant to the Company’s Restricted Share Unit (“RSU”) Incentive Plan approved by the board of directors of the Company on June 8, 2015, restricted stock units to acquire common shares of the Company may be granted to specified service providers of the Company in accordance with the terms and conditions of the plan. Upon vesting, each RSU entitles the participant to receive one common share, provided that the participant is continuously employed with or providing services to the Company. RSUs track the value of the underlying common shares, but do not entitle the recipient to the underlying common shares until such RSUs vest, nor do they entitle a holder to exercise voting rights or any other rights attached to ownership or control of the common shares, until the RSU vests and the RSU participant receives common shares. A summary of the Company’s RSU’s are as follows: Schedule of restricted share units Number of RSUs Outstanding, December 31, 2020 — Issued 166,000 Outstanding, December 31, 2021 166,000 Vested (166,000 ) — — Outstanding, December 31, 2022 and December 31, 2023 — On April 27, 2021 the Company issued 166,000 RSU’s to directors and officers of the Company that vested on November 17, 2022. At December 31, 2023, there were nil RSUs outstanding (December 31, 2022 – nil; December 31, 2021 – 166,000). During the year ended December 31, 2023, the Company recorded $ 0 696 216 14.6 Deferred Share Units Pursuant to the Company’s Deferred Share Unit (“DSU”) Incentive Plan approved by the board of directors of the Company on July 8, 2018, deferred stock units to acquire common shares of the Company may be granted to specified board members of the Company in accordance with the terms and conditions of the plan. Each DSU entitles the participant to receive one common share upon vesting. DSUs vest into common shares on the board members’ separation date from the board of directors. DSUs track the value of the underlying common shares, but do not entitle the recipient to the underlying common shares until such DSUs vest, nor do they entitle a holder to exercise voting rights or any other rights attached to ownership or control of the common shares, until the DSU vests and the DSU participant receives common shares. A summary of the Company’s DSUs are as follows: Schedule of deferred share units Number of DSUs Outstanding, December 31, 2020 95,141 Issued 75,650 Outstanding, December 31, 2021 170,791 Issued 452,910 Outstanding, December 31, 2022 623,701 Issued 666,749 Outstanding, December 31, 2023 1,290,450 During the year ended December 31, 2023, the Company issued 666,749 452,910 75,650 During the year ended December 31, 2023, the Company recorded $ 555 569 December 31, 2021 - $ 323 |